TICRX Mutual Fund

NAV$26.98

Fund Essentials - as of Feb 27, 2026

Net Assets
$435M
Expense Ratio
0.49%
Dividend Yield (Current)
8.06%
Holdings
130
Inception Date
Mar 31, 2006
Fund Family
Nuveen
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.03%
1 Year+11.27%
3 Year+14.85%
5 Year+8.00%
10 Year+12.71%

Asset Allocation

Stocks: 99.50%
Bonds: 0.30%
Other: 0.20%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp8.10%
GOOGAlphabet Inc series C3.30%
PGProcter & Gamble Co/The Pg Us Equity2.60%
AVGOBroadcom Inc2.40%
JPM:USJp Morgan Chase & Co2.20%
Top 10 Concentration: 28.10%Report Date: Feb 27, 2026
Download all 130 holdings for TICRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
8.06%
Frequency
Annually
Latest Distribution
$2.62
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how TICRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

TICRX Mutual Fund Overview

TICRX Mutual Fund (Nuveen Large Cap Responsible Equity Fund Class A) is managed by Nuveen with $435.0M in net assets. TICRX expense ratio is 0.49%, holding 130 positions across sectors including Information Technology, Financials, Consumer Discretionary. Inception date: 2006-03-31.

TICRX performance shows a YTD return of 13.03%. The 1-year return is 11.27% and the 5-year return is 8.00%. TICRX dividend yield stands at 8.06%, paid annually.

TICRX top holdings include Nvidia Corp (8.1%), Alphabet Inc series C (3.3%), Procter & Gamble Co/The Pg Us Equity (2.6%), Broadcom Inc (2.4%), Jp Morgan Chase & Co (2.2%). View all TICRX holdings, sector breakdown, or dividend history.

TICRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. TICRX alternatives are available via the screener, along with tax-loss harvesting opportunities.